SBIR/STTR Research Award

Establishment of human mini-Testis for reproductive toxicity testing

Award identifier baa605ae978f05e2b5e80da4e408d40449d2cef66259260988ce246d7fbf1076Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
REPROTOX BIOTECH L.L.C.
Proposal award date
2020-08-01
Contract end date
2021-02-28
UEI
EM3BV8FFL8C7
Solicitation number
PA19-272
Topic code
NIEHS

Research abstract

SummaryOccupational exposures during manufacture and application of these chemicals represent the highest level of exposure that could cause potential adverse health effects. There remains a considerable knowledge gap regarding the relationship between workplace exposure of industrial chemicals and possible adverse health effects. Current test methods set by regulatory agencies predominately rely on animal testing. The cost and time with the animal testing for risk assessment seriously limit efforts for extensive chemical screening. These data gaps necessitate the implementation of a new vision for toxicity testing as reflected in the National Research Council’s report “Toxicity Testing in the 21st Century”. Under the support of NIOSH R21 OH010473 grant, we established a rodent testicular cell co-culture model and found this in vitro co-culture model could identify the reproductive toxicants. While results from these in vivo or in vitro rodent models are informative, these models could not recapitulate the whole process of human spermatogenesis as rodent spermatogenesis proceeds in a distinctly different fashion compared to humans. Thus, developing in vitro human models for reproductive toxicity testing is paramount for advancing the field and for understanding the cellular and molecular mechanisms that may underlie these disruptions in human spermatogenesis. In this proposal, we will develop a human testicular cell co-culture model, and demonstrate the reliability and sensitivity of this model in high-throughput and multi-parametric high-content analytical screening for workplace chemicals on the reproductive and developmental systems. The specific aims are (1) to establish testicular cell co-culture model from human spermatogonial stem cells (hSSCs), Sertoli cell and Leydig cells; (2) to develop integrated assays based on the adverse outcome pathways; (3) to apply the multi-parametric high-throughput and high- content analysis (HT/HCA) to examine and compare reproductive toxic and non-toxic compounds to validate the in vitro testicular cell co-culture model. Through this hypothesis-driven research, we will test the hypothesis that an in vitro 3D human testicular cell co-culture model creates a proper microenvironment that mimics a human testis to promote the growth of germ cells in vitro and generate reproducible results for predicting reproductive toxicity. The research proposed will result in publications and generate toxicity data of the chemicals in the workplace, and provide data for risk assessment. Therefore, this proposal meets the mission of Cancer, Reproductive, and Cardiovascular Research Program (CRC). The identification of reproductive toxicants will reduce hazardous exposures and lower the risk of reproductive malfunction. Therefore, our proposed project is within the NIOSH CRC’s Research to Practice (r2p) strategy to promote the transfer and translation of research findings into prevention practices.Project narrativeWe will generate human spermatogonia stem cells (hSSCs) from differentiating human embryonic stem cells (hESCs) and establish three-dimensional (3D) in vitro human testicular cell co-culture model (human mini-testis). We will also develop integrated pathway-based assays associated with the adverse outcome of reproductive toxicity. Cost-efficient, pathway-based in vitro human mini-testis will be valuable for the screening of potential reproductive toxicity of drugs or chemicals in the environment.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2016–2020). Reported award amounts total $1,886,977. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.